Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Read more about Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Post-COVID-19 Condition: Observational Study in Vietnam Read more about Post-COVID-19 Condition: Observational Study in Vietnam
Additional Recombinant COVID-19 Humoral and Cell-Mediated Immunogenicity in Immunosuppressed Populations Read more about Additional Recombinant COVID-19 Humoral and Cell-Mediated Immunogenicity in Immunosuppressed Populations
Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCU Read more about Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCU
Reducing COVID-19 Vaccine Hesitancy Among Hispanic Parents Read more about Reducing COVID-19 Vaccine Hesitancy Among Hispanic Parents
Objective Evaluation of the Effect of Oculoplastic Operations Using the Vectra M 3D Imaging System Read more about Objective Evaluation of the Effect of Oculoplastic Operations Using the Vectra M 3D Imaging System
Safety of Simultaneous mRNA COVID-19 Vaccine With Other Childhood Vaccines in Young Children Read more about Safety of Simultaneous mRNA COVID-19 Vaccine With Other Childhood Vaccines in Young Children
Modified Thoracoabdominal Nerve Block(M-TAPA) in Pediatric Laparoscopic Appendectomies Read more about Modified Thoracoabdominal Nerve Block(M-TAPA) in Pediatric Laparoscopic Appendectomies
A Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) (Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180)) in Japanese Participants With Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (R/M cSCC) or Locally Advanced (LA) Read more about A Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) (Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180)) in Japanese Participants With Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (R/M cSCC) or Locally Advanced (LA)
Cognitive Impairment and Fatigue After Mild to Moderate COVID-19 Read more about Cognitive Impairment and Fatigue After Mild to Moderate COVID-19
